248 related articles for article (PubMed ID: 22539989)
1. Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis.
Kushawaha PK; Gupta R; Tripathi CD; Sundar S; Dube A
PLoS One; 2012; 7(4):e35670. PubMed ID: 22539989
[TBL] [Abstract][Full Text] [Related]
2. Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.
Jaiswal AK; Khare P; Joshi S; Kushawaha PK; Sundar S; Dube A
PLoS One; 2014; 9(9):e108556. PubMed ID: 25268700
[TBL] [Abstract][Full Text] [Related]
3. Characterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis.
Gupta R; Kumar V; Kushawaha PK; Tripathi CP; Joshi S; Sahasrabuddhe AA; Mitra K; Sundar S; Siddiqi MI; Dube A
PLoS One; 2014; 9(1):e86073. PubMed ID: 24475071
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis.
Khare P; Jaiswal AK; Tripathi CD; Joshi S; Sundar S; Dube A
Parasitol Res; 2014 Mar; 113(3):851-62. PubMed ID: 24370734
[TBL] [Abstract][Full Text] [Related]
5. Molecular, biochemical characterization and assessment of immunogenic potential of cofactor-independent phosphoglycerate mutase against Leishmania donovani: a step towards exploring novel vaccine candidate.
Tandon R; Chandra S; Baharia RK; Misra P; Das S; Rawat K; Siddiqi MI; Sundar S; Dube A
Parasitology; 2018 Apr; 145(4):508-526. PubMed ID: 28691653
[TBL] [Abstract][Full Text] [Related]
6. Nucleosomal histone proteins of L. donovani: a combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters.
Baharia RK; Tandon R; Sahasrabuddhe AA; Sundar S; Dube A
PLoS One; 2014; 9(6):e97911. PubMed ID: 24926878
[TBL] [Abstract][Full Text] [Related]
7. Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis.
Kushawaha PK; Gupta R; Tripathi CD; Khare P; Jaiswal AK; Sundar S; Dube A
PLoS One; 2012; 7(9):e45766. PubMed ID: 23049855
[TBL] [Abstract][Full Text] [Related]
8. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
9. Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.
Khare P; Jaiswal AK; Tripathi CD; Sundar S; Dube A
Clin Exp Immunol; 2016 Aug; 185(2):165-79. PubMed ID: 26898994
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Leishmania donovani disulfide isomerase as a potential target of cellular immunity against visceral leishmaniasis.
Amit A; Chaudhary R; Yadav A; Suman SS; Narayan S; Das VN; Pandey K; Singh SK; Singh BK; Ali V; Das P; Bimal S
Cell Immunol; 2014; 289(1-2):76-85. PubMed ID: 24732062
[TBL] [Abstract][Full Text] [Related]
11. Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb/c mice.
Amit A; Vijayamahantesh ; Dikhit MR; Singh AK; Kumar V; Suman SS; Singh A; Kumar A; Thakur AK; Das VR; Das P; Bimal S
Mol Immunol; 2017 Feb; 82():104-113. PubMed ID: 28064069
[TBL] [Abstract][Full Text] [Related]
12. Immunological characterization of rLdTCP1γ for its prophylactic potential against visceral leishmaniasis in hamster model.
Anand A; Balodi DC; Ramalingam K; Yadav S; Goyal N
Mol Immunol; 2022 Jan; 141():33-42. PubMed ID: 34798496
[TBL] [Abstract][Full Text] [Related]
13. A Chimera of Th1 Stimulatory Proteins of
Ratnapriya S; Keerti ; Yadav NK; Dube A; Sahasrabuddhe AA
Biomed Res Int; 2021; 2021():8845826. PubMed ID: 34095312
[TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
[TBL] [Abstract][Full Text] [Related]
15. Antigenicity of
Fernández L; Carrillo E; Sánchez-Sampedro L; Sánchez C; Ibarra-Meneses AV; Jimenez MA; Almeida VDA; Esteban M; Moreno J
Front Immunol; 2018; 9():843. PubMed ID: 29740446
[No Abstract] [Full Text] [Related]
16. Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.
Baharia RK; Tandon R; Sharma T; Suthar MK; Das S; Siddiqi MI; Saxena JK; Sundar S; Dube A
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003557. PubMed ID: 25745863
[TBL] [Abstract][Full Text] [Related]
17. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis.
Basu R; Bhaumik S; Basu JM; Naskar K; De T; Roy S
J Immunol; 2005 Jun; 174(11):7160-71. PubMed ID: 15905560
[TBL] [Abstract][Full Text] [Related]
18. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
Kumari S; Samant M; Misra P; Khare P; Sisodia B; Shasany AK; Dube A
Vaccine; 2008 Oct; 26(45):5700-11. PubMed ID: 18762224
[TBL] [Abstract][Full Text] [Related]
19. Kinesin motor domain of Leishmania donovani as a future vaccine candidate.
Dey A; Sharma P; Redhu NS; Singh S
Clin Vaccine Immunol; 2008 May; 15(5):836-42. PubMed ID: 18353921
[TBL] [Abstract][Full Text] [Related]
20. Immunological consequences of stress-related proteins--cytosolic tryparedoxin peroxidase and chaperonin TCP20--identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasis.
Jaiswal AK; Khare P; Joshi S; Rawat K; Yadav N; Sundar S; Dube A
Parasitology; 2015 Apr; 142(5):728-44. PubMed ID: 25498563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
